Skip to main content
. 2021 Feb 28;13(3):803. doi: 10.3390/nu13030803

Figure 3.

Figure 3

Summary of the molecular mechanisms reported in recent literature potentially mediating the beneficial effects of methylxanthines in respect to multiple sclerosis. Ac = Acetylation, eEF1A1 = eukaryotic translation elongation factor 1 alpha 1, HDAC2 = histone deacetylase 2, SOX10 = SRY-box transcription factor 10, MBP = myelin basic protein, ROS = reactive oxygen species, SOD1 = superoxide dismutase 1, c-Rel = proto-oncogene c-Rel, NSC = neuronal stem cells, PI3Kδ = phosphatidylinositol-3-kinase delta.